2020 Annual Meeting | Contemporary Clinical Issues Plenary Session
| 09:15 AM - 09:30 AM | Speaker |
Improvement in Mood in Patients Receiving Blue Light Therapy Following a Mild Traumatic Brain Injury (mTBI)
Bradley Shane, MD |
| 09:30 AM - 09:40 AM | Speaker |
Discussant: Improvement in Mood in Patients Receiving Blue Light Therapy Following a Mild Traumatic Brian Injury (mTBI)
Phyllis C. Zee, MD, PhD |
| 09:40 AM - 09:55 AM | Speaker |
Radiologically Isolated Syndrome: A 10-year Follow-up Study to Identify Factors Predicting a First Clinical Event
|
| 09:55 AM - 10:05 AM | Speaker |
Discussant: Radiologically Isolated Syndrome: A 10-year Follow-up Study to Identify Factors Predicting a First Clinical Event
Luanne Metz, MD |
| 10:05 AM - 10:20 AM | Speaker |
Leisure Time Physical Activity and MRI-based Brain Measures in a Multi-ethnic Elderly Cohort
Yian Gu, PhD |
| 10:20 AM - 10:30 AM | Speaker |
Discussant: Leisure Time Physical Activity and MRI-based Brain Measures in a Multi-ethnic Elderly Cohort
Rebecca F. Gottesman, MD |
| 10:30 AM - 10:50 AM | Speaker |
Gene Therapy for Childhood Neuromuscular Syndromes
Perry Shieh, MD, PhD, FAAN |
| 10:50 AM - 11:10 AM | Speaker |
Immuno-oncology: Neurological Complications
Karin Woodman, MD |
| 11:10 AM - 11:30 AM | Speaker |
Stem Cell Tourism/Regenerative Medicine
Sean I. Savitz, MD |
| Randolph S. Marshall, MD, FAAN | The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
| Yian Gu, PhD | The institution of Dr. Gu has received research support from NIH. |
| No disclosure on file | |
| Luanne Metz, MD | The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta. |
| Bradley Shane, MD | Dr. Shane has nothing to disclose. |
| Phyllis C. Zee, MD, PhD | Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care. |
| Perry Shieh, MD, PhD, FAAN | Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. |
| Sean I. Savitz, MD | Dr. Savitz has nothing to disclose. |
| Rebecca F. Gottesman, MD | The institution of Dr. Gottesman has received research support from NIH. |
| Karin Woodman, MD | Dr. Woodman has nothing to disclose. |